Search
for
Sort by
Research 511–540 of 999
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics‐Treated Men With Hyperprolactinemia and Early‐Onset Androgenic Alopecia
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- Role of regeneration in tissue repairing and therapies
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Polycystic ovary syndrome
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Erosive Pustular Dermatosis: A Manifestation of Immunosenescence A Report of 8 Cases
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Endocrinology
- Involvement of neurosteroids in the control of prolactin secretion in sheep under basal, stressful and pregnancy conditions
- The effect of hormones of the hypothalamic-pituitary-target gland axes in a kidney-yang deficiency syndrome model
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- Current Guidelines for Diagnosing PCOS
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess